D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 92,400
+3,600 (4.05%)
At close: Feb 27, 2026
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 4.02 trillion as of February 27, 2026. Its market cap has increased by 559.70% in one year.
Market Cap
4.02T
Enterprise Value
3.99T
Revenue
8.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
92,400.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 4.02T, an increase of 959.82%. That is a compound annual growth rate of 264.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 4.02T | 0.65% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 9.22T |
| HLB Co., Ltd. | 6.90T |
| LigaChem Biosciences | 6.82T |
| Peptron | 6.68T |
| Voronoi | 5.64T |
| SK bioscience | 3.91T |
| PharmaResearch | 3.63T |
| OliX Pharmaceuticals | 3.22T |